WYOST is BACKED BY SANDOZ, a global leader in biosimilars with 25+ years of experience4


Confirmed biosimilarity
Review the totality of evidence for WYOST, including results from the Phase3 ROSALIA study.


Support from Sandoz One Source
Get comprehensive support services for your patients and practice.


Backed by Sandoz
Sandoz is a global leader in biosimilars with 25+ years of experience.